Skip to main content
. Author manuscript; available in PMC: 2009 Feb 23.
Published in final edited form as: Cancer Biother Radiopharm. 2006 Apr;21(2):155–166. doi: 10.1089/cbr.2006.21.155

Figure 3.

Figure 3

Single flank tumor mean volume (cm3) starting one week before first dose administration through day 44 of study. Dose administration occurred on days 0, 7, 14, 21, and 28. Study group tumor mean (cm3) +/- standard deviation on days 33 and 44 as follows: 0.353 ± 0.14 and 0.563 ± 0.11 for Control; 0.153 ± 0.10 and 0.264 ± 0.17 for docetaxel + estramustine (EMP); 0.056 ± 0.07 and 0.095 ± 0.11 for docetaxel; 0.057 ± 0.03 and 0.083 ± 0.05 for targeted radiotherapy (TRT); 0.015 ± 0.01 and 0.019 ± 0.02 for TRT + docetaxel; and 0.020 ± 0.01 and 0.022 ± 0.02 for TRT + docetaxel + EMP.